166 related articles for article (PubMed ID: 3794935)
1. Lactulose-rhamnose intestinal permeability in children with cystic fibrosis.
Leclercq-Foucart J; Forget PP; Van Cutsem JL
J Pediatr Gastroenterol Nutr; 1987; 6(1):66-70. PubMed ID: 3794935
[TBL] [Abstract][Full Text] [Related]
2. Intestinal malabsorption in cystic fibrosis.
Penny DJ; Ingall CB; Boulton P; Walker-Smith JA; Basheer SM
Arch Dis Child; 1986 Nov; 61(11):1127-8. PubMed ID: 3789793
[TBL] [Abstract][Full Text] [Related]
3. Oral chenodeoxycholic acid increases small intestinal permeability to lactulose in humans.
Erickson RA; Epsten RM
Am J Gastroenterol; 1988 May; 83(5):541-4. PubMed ID: 3129932
[TBL] [Abstract][Full Text] [Related]
4. Increased lactulose/rhamnose ratio during fluid load is caused by increased urinary lactulose excretion.
Hallemeesch MM; Lamers WH; Soeters PB; Deutz NE
Am J Physiol Gastrointest Liver Physiol; 2000 Jan; 278(1):G83-8. PubMed ID: 10644565
[TBL] [Abstract][Full Text] [Related]
5. Effects of therapy with lansoprazole on intestinal permeability and inflammation in young cystic fibrosis patients.
Hendriks HJ; van Kreel B; Forget PP
J Pediatr Gastroenterol Nutr; 2001 Sep; 33(3):260-5. PubMed ID: 11593119
[TBL] [Abstract][Full Text] [Related]
6. Intestinal permeability in cystic fibrosis in relation to genotype.
Hallberg K; Grzegorczyk A; Larson G; Strandvik B
J Pediatr Gastroenterol Nutr; 1997 Sep; 25(3):290-5. PubMed ID: 9285379
[TBL] [Abstract][Full Text] [Related]
7. Lactulose, 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 400 [corrected] as probe markers for assessment in vivo of human intestinal permeability.
Maxton DG; Bjarnason I; Reynolds AP; Catt SD; Peters TJ; Menzies IS
Clin Sci (Lond); 1986 Jul; 71(1):71-80. PubMed ID: 3086024
[TBL] [Abstract][Full Text] [Related]
8. Abnormal intestinal permeability to sugars in villous atrophy.
Menzies IS; Laker MF; Pounder R; Bull J; Heyer S; Wheeler PG; Creamer B
Lancet; 1979 Nov; 2(8152):1107-9. PubMed ID: 91841
[TBL] [Abstract][Full Text] [Related]
9. Rapid and simultaneous quantification of rhamnose, mannitol, and lactulose in urine by HPLC for estimating intestinal permeability in pediatric practice.
Miki K; Butler R; Moore D; Davidson G
Clin Chem; 1996 Jan; 42(1):71-5. PubMed ID: 8565237
[TBL] [Abstract][Full Text] [Related]
10. Simple and sensitive multi-sugar-probe gut permeability test by high-performance liquid chromatography with fluorescence labelling.
Rooyakkers DR; van Eijk HM; Deutz NE
J Chromatogr A; 1996 Apr; 730(1-2):99-105. PubMed ID: 8680601
[TBL] [Abstract][Full Text] [Related]
11. The sensitivity of the lactulose/rhamnose gut permeability test.
van Nieuwenhoven MA; Geerling BJ; Deutz NE; Brouns F; Brummer RJ
Eur J Clin Invest; 1999 Feb; 29(2):160-5. PubMed ID: 10093003
[TBL] [Abstract][Full Text] [Related]
12. Lactulose-L-rhamnose intestinal permeability test in patients with liver cirrhosis.
Fujii T; Seki T; Maruoka M; Tanaka J; Kawashima Y; Watanabe T; Sawamura T; Inoue K
Hepatol Res; 2001 Feb; 19(2):158-169. PubMed ID: 11164740
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin and human intestinal permeability.
Budillon G; Parrilli G; D'Agostino L; Capuano G; Mazzacca G; Menzies IS
Digestion; 1980; 20(1):68-72. PubMed ID: 7353735
[TBL] [Abstract][Full Text] [Related]
14. Intestinal permeability and lactose hydrolysis in human rotaviral gastroenteritis assessed simultaneously by non-invasive differential sugar permeation.
Noone C; Menzies IS; Banatvala JE; Scopes JW
Eur J Clin Invest; 1986 Jun; 16(3):217-25. PubMed ID: 3089818
[TBL] [Abstract][Full Text] [Related]
15. Thin-layer chromatographic determination of urinary excretion of lactulose, simplified and applied to cystic fibrosis patients.
Flick JA; Schnaar RL; Perman JA
Clin Chem; 1987 Jul; 33(7):1211-2. PubMed ID: 3594850
[TBL] [Abstract][Full Text] [Related]
16. Improvement of abnormal lactulose/rhamnose permeability in active Crohn's disease of the small bowel by an elemental diet.
Sanderson IR; Boulton P; Menzies I; Walker-Smith JA
Gut; 1987 Sep; 28(9):1073-6. PubMed ID: 3678965
[TBL] [Abstract][Full Text] [Related]
17. Increased intestinal permeability in atopic eczema.
Pike MG; Heddle RJ; Boulton P; Turner MW; Atherton DJ
J Invest Dermatol; 1986 Feb; 86(2):101-4. PubMed ID: 3745938
[TBL] [Abstract][Full Text] [Related]
18. Comparison of four markers of intestinal permeability in control subjects and patients with coeliac disease.
Bjarnason I; Maxton D; Reynolds AP; Catt S; Peters TJ; Menzies IS
Scand J Gastroenterol; 1994 Jul; 29(7):630-9. PubMed ID: 7939400
[TBL] [Abstract][Full Text] [Related]
19. Local effect of adenosine 5'-triphosphate on indomethacin-induced permeability changes in the human small intestine.
Bours MJ; Troost FJ; Brummer RJ; Bast A; Dagnelie PC
Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):245-50. PubMed ID: 17301652
[TBL] [Abstract][Full Text] [Related]
20. Effects of oral adenosine 5'-triphosphate and adenosine in enteric-coated capsules on indomethacin-induced permeability changes in the human small intestine: a randomized cross-over study.
Bours MJ; Bos HJ; Meddings JB; Brummer RJ; van den Brandt PA; Dagnelie PC
BMC Gastroenterol; 2007 Jun; 7():23. PubMed ID: 17578566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
